Urgent Recall: Emerade Adrenaline Pens Pulled Over Safety Fears
Patients using Emerade 300 or 500 microgram adrenaline auto-injector pens must act now. Health chiefs urge patients and carers to contact their GP immediately for a new prescription and switch to alternative brands like EpiPen or Jext. Once swapped, all Emerade pens should be returned to local pharmacies without delay.
Why The Recall?
The recall comes after tests showed some Emerade pens might fail to work properly if dropped. They could either deliver the adrenaline dose too early or not at all – a dangerous risk in emergencies. The fault was found during a manufacturer’s design check and affects both 300mcg and 500mcg Emerade pens.
How To Stay Safe
- Get a GP prescription for two replacement pens in the correct dose.
- Collect EpiPen or Jext from your pharmacy.
- Return all Emerade pens only after you have your replacements.
- Learn how to use your new pen—each brand works differently.
- Keep carrying two pens at all times, as always.
Pharmacists and nurses can provide advice and instruction. Replacement pens come with detailed guides and links to manufacturer videos to help patients master their use.
Health Official Speaks Out
Dr Alison Cave, MHRA Chief Safety Officer:
“Patient safety is our top priority. We are taking prompt action after finding damage to Emerade pens when dropped, causing risks of premature or failed activation. There are enough EpiPen and Jext pens across the UK, but patients must request a new prescription.
Remember to carry two pens at all times and consult your healthcare professional when replacements are needed.”
